Marie-Luise Gross
Institute of Pathology
INF 220/221
69120 Heidelberg
Germany
Name/email consistency: high
- Glycated and carbamylated albumin are more "nephrotoxic" than unmodified albumin in the amphibian kidney. Gross, M.L., Piecha, G., Bierhaus, A., Hanke, W., Henle, T., Schirmacher, P., Ritz, E. Am. J. Physiol. Renal Physiol. (2011)
- Hypertrophy and fibrosis in the cardiomyopathy of uremia--beyond coronary heart disease. Gross, M.L., Ritz, E. Semin. Dial (2008)
- Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Gross, M.L., Meyer, H.P., Ziebart, H., Rieger, P., Wenzel, U., Amann, K., Berger, I., Adamczak, M., Schirmacher, P., Ritz, E. Clin. J. Am. Soc. Nephrol (2007)
- Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes. Gross, M.L., Koch, A., Mühlbauer, B., Adamczak, M., Ziebart, H., Drescher, K., Gross, G., Berger, I., Amann, K.U., Ritz, E. Lab. Invest. (2006)
- Renal failure and ACE inhibition: how much is too much?. Gross, M.L., Adamczak, M., Ritz, E. Z. Kardiol (2005)
- Effects of estrogens on cardiovascular structure in uninephrectomized SHRsp rats. Gross, M.L., Ritz, E., Korsch, M., Adamczak, M., Weckbach, M., Mall, G., Berger, I., Hansen, A., Amann, K. Kidney Int. (2005)
- ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes. Gross, M.L., Heiss, N., Weckbach, M., Hansen, A., El-Shakmak, A., Szabo, A., Münter, K., Ritz, E., Amann, K. Diabetologia (2004)
- Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats. Gross, M.L., Adamczak, M., Rabe, T., Harbi, N.A., Krtil, J., Koch, A., Hamar, P., Amann, K., Ritz, E. J. Am. Soc. Nephrol. (2004)
- Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes. Gross, M.L., Ritz, E., Schoof, A., Adamczak, M., Koch, A., Tulp, O., Parkman, A., El-Shakmak, A., Szabo, A., Amann, K. Lab. Invest. (2004)
- ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Gross, M.L., El-Shakmak, A., Szábó, A., Koch, A., Kuhlmann, A., Münter, K., Ritz, E., Amann, K. Diabetologia (2003)